Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
PGEN

PRECIGEN (PGEN) stock: insider trades, news & valuation

Health Care · Net selling
Close · Oct 9, 2026 $7.81 +2.8% on the day +144.8% over 12 months 52-week range $3.10 – $8.56

Share price and insider trades

PGEN closeInsider buyInsider sale
246810NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $24,662 on 2026-08-21 · Nancy H AgeeSold $219,518 on 2026-08-03 · Rutul R ShahSold $224,590 on 2026-08-06 · Rutul R ShahSold $259,935 on 2026-08-21 · Rutul R ShahSold $606,000 on 2026-07-31 · Harry Thomasian Jr.Sold $708,810 on 2026-08-25 · Phil Tennant, Rutul R ShahSold $854,745 on 2025-12-12 · Jeffrey B KindlerSold $948,002 on 2026-07-01 · Harry Thomasian Jr.Sold $1,147,726 on 2026-05-28 · Donald P. Lehr, Harry Thomasian Jr., Helen Sabzevari, Phil Tennant, Rutul R ShahSold $1,376,400 on 2026-08-26 · Jeffrey B KindlerSold $2,459,110 on 2026-06-29 · Harry Thomasian Jr., Helen Sabzevari, Rutul R ShahSold $3,589,890 on 2025-11-21 · Randal J KirkSold $3,846,755 on 2025-11-20 · Randal J KirkSold $4,855,104 on 2025-11-19 · Randal J KirkSold $7,942,150 on 2025-12-22 · Randal J KirkSold $15,750,177 on 2026-03-30 · Randal J Kirk
Bought, 12 months$25K
Sold, 12 months$44.8M
Insiders buying1
Insiders selling7

PRECIGEN insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $25K and 7 sold $44.8M of PGEN stock on the open market.

PGEN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2025: $604K sold (2 trades)Q3 2025Q4 2025: $21.1M sold (15 trades)Q4 2025Q1 2026: $15.8M sold (11 trades)Q1 2026Q2 2026: $3.6M sold (8 trades)Q2 2026Q3 2026: $25K bought (1 trades)$25KQ3 2026: $4.3M sold (8 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$25K1$4.3M8
Q2 2026—0$3.6M8
Q1 2026—0$15.8M11
Q4 2025—0$21.1M15
Q3 2025—0$604K2

Valuation, profit and volume

Pick score 36/100
P/E (trailing)n/aSector median 24.7
Market value$2.80BBiotechnology
Profit margin-184.0%Revenue growth +6322.7%
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit+$2KOn all tracked purchases +8.0%

Summary

Over the past 12 months, 1 PRECIGEN, INC. insider reported open-market purchases totaling $25K, while 7 insiders reported sales totaling $44.8M. 10 of 44 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

PGEN stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 28SEC Jeffrey B KindlerDirector Sell 185,00017,100 held (−92%) $7.44 $1.4M +5.0% —
Aug 25SEC Phil TennantChief Commercial Officer Sell Plan 79,166141,992 held (−36%) $7.50 $594K +4.1% —
Aug 25SEC Rutul R ShahCOO Sell Plan 34,658465,012 held (−7%) $7.50 $260K +4.1% —
Aug 25SEC Rutul R ShahCOO Sell Plan 15,342468,865 held (−3%) $7.50 $115K +4.1% —
Aug 25SEC Nancy H AgeeDirector Buy 3,411309,187 held (+1%) $7.23 $25K +8.0% —
Aug 7SEC Rutul R ShahCOO Sell Plan 32,739465,012 held (−7%) $6.86 $225K +13.8% —
Aug 3SEC Rutul R ShahCOO Sell Plan 33,772497,751 held (−6%) $6.50 $220K +20.2% —
Jul 31SEC Harry Thomasian Jr.CFO Sell Plan 100,000254,535 held (−28%) $6.06 $606K +28.9% —
Jul 1SEC Helen SabzevariCEO, President Sell Plan 346,8363,768,872 held (−8%) $5.89 $2.0M +32.6% —
Jul 1SEC Harry Thomasian Jr.CFO Sell Plan 171,429354,535 held (−33%) $5.53 $948K +41.2% —
Jul 1SEC Rutul R ShahCOO Sell Plan 42,924497,751 held (−8%) $5.85 $251K +33.5% —
Jul 1SEC Harry Thomasian Jr.CFO Sell Plan 28,571525,964 held (−5%) $5.78 $165K +35.1% —
Jun 1SEC Helen SabzevariCEO, President Sell 119,2503,768,872 held (−3%) $4.36 $520K +79.1% —
Jun 1SEC Rutul R ShahCOO Sell 42,703497,751 held (−8%) $4.36 $186K +79.1% —
Jun 1SEC Harry Thomasian Jr.CFO Sell 41,884554,535 held (−7%) $4.36 $183K +79.1% —
Jun 1SEC Phil TennantChief Commercial Officer Sell 30,272139,369 held (−18%) $4.36 $132K +79.1% —
Jun 1SEC Donald P. LehrGeneral Counsel Sell 29,131755,461 held (−4%) $4.36 $127K +79.1% —
Mar 31SEC Randal J KirkDirector Sell 2,334,42012,262,741 held (−16%) $3.30 $7.7M +136.7% —
Mar 31SEC Randal J KirkDirector Sell 1,108,99880,672,818 held (−1%) $3.30 $3.7M +136.7% —
Mar 31SEC Randal J KirkDirector Sell 426,1993,358,917 held (−11%) $3.30 $1.4M +136.7% —
Mar 31SEC Randal J KirkDirector Sell 370,8473,238,210 held (−10%) $3.30 $1.2M +136.7% —
Mar 31SEC Randal J KirkDirector Sell 168,7941,425,544 held (−11%) $3.30 $557K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 152,0631,463,571 held (−9%) $3.30 $502K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 50,797426,695 held (−11%) $3.30 $168K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 50,797425,732 held (−11%) $3.30 $168K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 47,101519,061 held (−8%) $3.30 $155K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 38,976302,213 held (−11%) $3.30 $129K +136.7% —
Mar 31SEC Randal J KirkDirector Sell 23,789423,984 held (−5%) $3.30 $79K +136.7% —
Dec 22SEC Randal J KirkDirector Sell 956,2004,598,044 held (−17%) $4.18 $4.0M +86.8% —
Dec 22SEC Randal J KirkDirector Sell 555,11981,609,648 held (−1%) $4.18 $2.3M +86.8% —
Dec 22SEC Randal J KirkDirector Sell 159,3213,785,116 held (−4%) $4.18 $666K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 94,3413,609,057 held (−3%) $4.18 $394K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 42,7021,594,338 held (−3%) $4.18 $178K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 38,7291,615,634 held (−2%) $4.18 $162K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 12,909477,492 held (−3%) $4.18 $54K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 12,909476,529 held (−3%) $4.18 $54K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 11,917566,162 held (−2%) $4.18 $50K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 9,931341,189 held (−3%) $4.18 $42K +86.8% —
Dec 22SEC Randal J KirkDirector Sell 5,958447,773 held (−1%) $4.18 $25K +86.8% —
Dec 16SEC Jeffrey B KindlerDirector Sell 235,467110,603 held (−68%) $3.63 $855K +115.2% —
Nov 21SEC Randal J KirkDirector Sell 1,086,1537,434,384 held (−13%) $4.47 $4.9M +74.7% —
Nov 21SEC Randal J KirkDirector Sell 942,8326,491,552 held (−13%) $4.08 $3.8M +91.4% —
Nov 21SEC Randal J KirkDirector Sell 937,3085,554,244 held (−14%) $3.83 $3.6M +103.9% —
Oct 1SEC Jeffrey B KindlerDirector Sell 106,837346,070 held (−24%) $3.38 $361K +131.1% —
Oct 1SEC Jeffrey B KindlerDirector Sell 67,523452,907 held (−13%) $3.60 $243K +116.9% —

Insiders at PRECIGEN, INC.

InsiderBoughtSoldLast filingScore
Randal J KirkDirector — $36.0M Mar 31, 2026 —
Jeffrey B KindlerDirector — $2.8M Aug 28, 2026 —
Helen SabzevariCEO, President — $2.6M Jul 1, 2026 —
Harry Thomasian Jr.CFO — $1.9M Jul 31, 2026 —
Rutul R ShahCOO — $1.3M Aug 25, 2026 —
Phil TennantChief Commercial Officer — $726K Aug 25, 2026 —
Donald P. LehrGeneral Counsel — $127K Jun 1, 2026 —
Nancy H AgeeDirector $25K — Aug 25, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

PGEN stock: common questions

Are PRECIGEN, INC. insiders buying PGEN stock?

In the past 12 months, 1 insiders reported open-market purchases of PGEN worth $25K. The latest was Director Nancy H Agee bought $25K of PGEN at $7.23 — first open-market purchase in our records.

Are PRECIGEN, INC. insiders selling PGEN stock?

7 insiders reported sales worth $44.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PGEN's 52-week range?

Over the past year PGEN has traded between $3.10 and $8.56. It last closed at $7.81 on Oct 9, 2026.